Position in AMGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$498,277
+$28,558 QoQ
Shares Held
1,376
+3.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,185
of 3,140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crewe Advisors LLC holds $5,785,083 across 15 Drug Manufacturers - General names. AMGN ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
10,490 | $1,347,965 | |
| 2 | LLY |
ELI LILLY & Co
|
962 | $1,153,851 | |
| 3 | JNJ |
Johnson & Johnson
|
3,263 | $828,704 | |
| 4 | ABBV |
AbbVie Inc.
|
2,981 | $750,138 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,376 | $498,277 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,950 | $458,079 | |
| 7 | PFE |
Pfizer Inc
|
13,048 | $314,195 | |
| 8 | AZN |
Astrazeneca PLC
|
967 | $183,362 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $498,277 | 1,376 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $469,719 | 1,335 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $427,139 | 1,305 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $365,449 | 1,295 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $361,297 | 1,294 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $397,849 | 1,277 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $334,401 | 1,283 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $467,848 | 1,452 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $451,802 | 1,446 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $422,215 | 1,485 | Shares | Sole | 2024-05-14 | |
| 2023-06-30 | $283,963 | 1,279 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $313,066 | 1,295 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $351,937 | 1,340 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $144,706 | 642 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $169,093 | 695 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $132,759 | 549 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $49,493 | 220 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $46,783 | 220 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $53,625 | 220 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $54,738 | 220 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $50,582 | 220 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $74,723 | 294 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $51,889 | 220 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $44,600 | 220 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||